These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 21812902)
1. Factors influencing post-recurrence survival in bladder cancer following radical cystectomy. Mitra AP; Quinn DI; Dorff TB; Skinner EC; Schuckman AK; Miranda G; Gill IS; Daneshmand S BJU Int; 2012 Mar; 109(6):846-54. PubMed ID: 21812902 [TBL] [Abstract][Full Text] [Related]
2. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy. Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876 [TBL] [Abstract][Full Text] [Related]
3. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion]. Słojewski M Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306 [TBL] [Abstract][Full Text] [Related]
4. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804 [TBL] [Abstract][Full Text] [Related]
5. Predictors of cancer-specific mortality after disease recurrence following radical cystectomy. Rink M; Lee DJ; Kent M; Xylinas E; Fritsche HM; Babjuk M; Brisuda A; Hansen J; Green DA; Aziz A; Cha EK; Novara G; Chun FK; Lotan Y; Bastian PJ; Tilki D; Gontero P; Pycha A; Baniel J; Mano R; Ficarra V; Trinh QD; Tagawa ST; Karakiewicz PI; Scherr DS; Sjoberg DD; Shariat SF; BJU Int; 2013 Mar; 111(3 Pt B):E30-6. PubMed ID: 22938654 [TBL] [Abstract][Full Text] [Related]
6. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy. Mitra AP; Alemozaffar M; Harris BN; Schuckman AK; Skinner EC; Daneshmand S Urology; 2014 Dec; 84(6):1420-6. PubMed ID: 25306479 [TBL] [Abstract][Full Text] [Related]
7. Twenty-year experience of radical cystectomy for bladder cancer in a medium-volume centre. Boström PJ; Mirtti T; Kössi J; Laato M; Nurmi M Scand J Urol Nephrol; 2009; 43(5):357-64. PubMed ID: 19921979 [TBL] [Abstract][Full Text] [Related]
8. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer. Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855 [TBL] [Abstract][Full Text] [Related]
9. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour. Solsona E; Iborra I; Rubio J; Casanova J; Almenar S BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101 [TBL] [Abstract][Full Text] [Related]
10. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer. Stein JP; Penson DF; Lee C; Cai J; Miranda G; Skinner DG J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213 [TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy. Bruins HM; Huang GJ; Cai J; Skinner DG; Stein JP; Penson DF J Urol; 2009 Nov; 182(5):2182-7. PubMed ID: 19758623 [TBL] [Abstract][Full Text] [Related]
12. Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy. Rink M; Hansen J; Cha EK; Green DA; Babjuk M; Svatek RS; Xylinas E; Tagawa ST; Faison T; Novara G; Karakiewicz PI; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Pycha A; Comploj E; Tilki D; Bastian PJ; Chun FK; Dahlem R; Scherr DS; Shariat SF BJU Int; 2013 Jan; 111(1):74-84. PubMed ID: 22809039 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy. Bruins HM; Wopat R; Mitra AP; Cai J; Miranda G; Skinner EC; Daneshmand S BJU Int; 2013 Mar; 111(3 Pt B):E37-42. PubMed ID: 22974410 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy. Kassouf W; Leibovici D; Munsell MF; Dinney CP; Grossman HB; Kamat AM J Urol; 2006 Jul; 176(1):53-7; discussion 57. PubMed ID: 16753366 [TBL] [Abstract][Full Text] [Related]
15. A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer. Mitra AP; Skinner EC; Miranda G; Daneshmand S BJU Int; 2013 Feb; 111(2):240-8. PubMed ID: 22928881 [TBL] [Abstract][Full Text] [Related]
16. Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder. Dhar NB; Jones JS; Reuther AM; Dreicer R; Campbell SC; Sanii K; Klein EA BJU Int; 2008 Apr; 101(8):969-72. PubMed ID: 18005201 [TBL] [Abstract][Full Text] [Related]
17. Upper urinary tract recurrence following radical cystectomy for bladder cancer. Furukawa J; Miyake H; Hara I; Takenaka A; Fujisawa M Int J Urol; 2007 Jun; 14(6):496-9. PubMed ID: 17593092 [TBL] [Abstract][Full Text] [Related]
18. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder. May M; Nitzke T; Helke C; Vogler H; Hoschke B Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377 [TBL] [Abstract][Full Text] [Related]